A timeline for Parkinson's disease.
暂无分享,去创建一个
[1] J. Holton,et al. Hyposmia in G2019S LRRK2-related parkinsonism , 2008, Neurology.
[2] H. Meltzer,et al. Reduced Levels of Norepinephrine Transporters in the Locus Coeruleus in Major Depression , 1997, The Journal of Neuroscience.
[3] G. Aston-Jones,et al. Locus coeruleus and regulation of behavioral flexibility and attention. , 2000, Progress in brain research.
[4] F. Verhey,et al. Higher incidence of depression preceding the onset of Parkinson's disease: A register study , 2003, Movement disorders : official journal of the Movement Disorder Society.
[5] Miguel A Hernán,et al. Obesity and the risk of Parkinson's disease. , 2004, American journal of epidemiology.
[6] H. Braak,et al. Parkinson's disease: a dual‐hit hypothesis , 2007, Neuropathology and applied neurobiology.
[7] P. Ragonese,et al. Parkinson disease survival: a population-based study. , 2000, Archives of neurology.
[8] C. Tanner,et al. Association of olfactory dysfunction with incidental Lewy bodies , 2006, Movement disorders : official journal of the Movement Disorder Society.
[9] G. Koob,et al. Drug addiction: Functional neurotoxicity of the brain reward systems , 2009, Neurotoxicity Research.
[10] S. Daniel,et al. Olfactory dysfunction in Parkinson's disease. , 1997, Journal of neurology, neurosurgery, and psychiatry.
[11] K. Jellinger. A critical reappraisal of current staging of Lewy-related pathology in human brain , 2008, Acta Neuropathologica.
[12] Bernardo Lanzillo,et al. Sensory deficit in Parkinson's disease: evidence of a cutaneous denervation. , 2008, Brain : a journal of neurology.
[13] R. Hauser,et al. Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease , 2008, Nature Medicine.
[14] N. Weinberger,et al. Behavioral memory induced by stimulation of the nucleus basalis: Effects of contingency reversal , 2009, Neurobiology of Learning and Memory.
[15] Satoshi Orimo,et al. Axonal α-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease , 2008 .
[16] M. Shibata,et al. Cardiac parasympathetic dysfunction concurrent with cardiac sympathetic denervation in Parkinson's disease , 2009, Journal of the Neurological Sciences.
[17] H. Braak,et al. Parkinson’s disease: the thalamic components of the limbic loop are severely impaired by α-synuclein immunopositive inclusion body pathology , 2002, Neurobiology of Aging.
[18] H. Braak,et al. Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered , 2006, Movement disorders : official journal of the Movement Disorder Society.
[19] H. Przuntek,et al. Progress of visual dysfunction in Parkinson's disease , 2002, Acta neurologica Scandinavica.
[20] K. Jellinger. The morphological basis of mental dysfunction in Parkinson's disease , 2006, Journal of the Neurological Sciences.
[21] José Luis Molinuevo,et al. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study , 2006, The Lancet Neurology.
[22] Elisabet Englund,et al. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation , 2008, Nature Medicine.
[23] R. Doty,et al. Olfactory dysfunction in parkinsonism , 1988, Neurology.
[24] C. Tanner,et al. Excessive daytime sleepiness and subsequent development of Parkinson disease , 2005, Neurology.
[25] D. Chateau,et al. Heterotypic sexual behavior in male rats after lesions in different amygdaloid nuclei , 1988, Hormones and Behavior.
[26] C. Tanner,et al. Bowel movement frequency in late‐life and incidental Lewy bodies , 2007, Movement disorders : official journal of the Movement Disorder Society.
[27] Robert E Burke,et al. A critical evaluation of the Braak staging scheme for Parkinson's disease , 2008, Annals of neurology.
[28] W. Oertel,et al. Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. , 2004, Brain : a journal of neurology.
[29] H. Braak,et al. Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology , 2006, Neuroscience Letters.
[30] L. Kessing,et al. Increased risk of developing Parkinson's disease for patients with major affective disorder: a register study. , 2001 .
[31] S. Lie,et al. Mortality and Parkinson disease , 2004, Neurology.
[32] C. Tanner,et al. Frequency of bowel movements and the future risk of Parkinson’s disease , 2001, Neurology.
[33] P. Damier,et al. Pathological lesions in colonic biopsies during Parkinson’s disease , 2008, Gut.
[34] D. Dickson,et al. Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.
[35] C. Tanner,et al. Midlife adiposity and the future risk of Parkinson’s disease , 2002, Neurology.
[36] A. Thorpe,et al. Peptides that regulate food intake: regional, metabolic, and circadian specificity of lateral hypothalamic orexin A feeding stimulation. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.
[37] K. Jellinger,et al. α-Synuclein pathology in Parkinson’s and Alzheimer’s disease brain: incidence and topographic distribution—a pilot study , 2003, Acta Neuropathologica.
[38] I. Alafuzoff,et al. α‐Synuclein pathology does not predict extrapyramidal symptoms or dementia , 2005, Annals of neurology.
[39] C. Hawkes. Parkinson's disease and aging: Same or different process? , 2008, Movement disorders : official journal of the Movement Disorder Society.
[40] F. Schmitt,et al. Lewy Body Pathology in Normal Elderly Subjects , 2009, Journal of neuropathology and experimental neurology.
[41] H. Braak,et al. Cortico-basal ganglia-cortical circuitry in Parkinson's disease reconsidered , 2008, Experimental Neurology.
[42] P. Ragonese,et al. Long–term survival of Parkinson's disease , 2005, Journal of Neurology.
[43] A M Stiggelbout,et al. Patient-reported autonomic symptoms in Parkinson disease , 2007, Neurology.
[44] K. Chaudhuri,et al. Non-motor symptoms of Parkinson's disease: diagnosis and management , 2006, The Lancet Neurology.
[45] A. Kakita,et al. Degeneration of Cardiac Sympathetic Nerve Begins in the Early Disease Process of Parkinson’s Disease , 2007, Brain pathology.
[46] Gary Aston-Jones,et al. Brain structures and receptors involved in alertness. , 2005, Sleep medicine.
[47] Mark W. Mahowald,et al. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder , 1996, Neurology.
[48] H. Braak,et al. Invited Article: Nervous system pathology in sporadic Parkinson disease , 2008, Neurology.
[49] A. Probst,et al. New insights into the pathology of Parkinson’s disease: does the peripheral autonomic system become central? , 2008, European journal of neurology.
[50] D. Munoz,et al. Do α-synuclein aggregates in autonomic plexuses predate Lewy body disorders? , 2007, Neurology.
[51] H. Braak,et al. Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.
[52] W. Paulus,et al. Acquired colour deficiency in patients with Parkinson’s disease , 1998, Vision Research.
[53] C. Hawkes. The prodromal phase of sporadic Parkinson's disease: Does it exist and if so how long is it? , 2008, Movement disorders : official journal of the Movement Disorder Society.
[54] K. Iwanaga,et al. Lewy body–type degeneration in cardiac plexus in Parkinson’s and incidental Lewy body diseases , 1999, Neurology.
[55] H. Braak,et al. Critical appraisal of brain pathology staging related to presymptomatic and symptomatic cases of sporadic Parkinson's disease. , 2006, Journal of neural transmission. Supplementum.
[56] Daniel J Schaid,et al. Survival study of Parkinson disease in Olmsted County, Minnesota. , 2003, Archives of neurology.
[57] R. Hauser,et al. Transplanted dopaminergic neurons develop PD pathologic changes: A second case report , 2008, Movement disorders : official journal of the Movement Disorder Society.
[58] E. Quigley,et al. Gastrointestinal dysfunction in Parkinson's disease , 1992, Neurology.
[59] M. Max,et al. Pain in Parkinson disease , 2004, Neurology.
[60] R. Postuma,et al. Manifestations of Parkinson disease differ in association with REM sleep behavior disorder , 2008, Movement disorders : official journal of the Movement Disorder Society.
[61] G Hu,et al. Body mass index and the risk of Parkinson disease , 2006, Neurology.
[62] L. Moran,et al. Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease. , 2009, Parkinsonism & related disorders.
[63] E. Rimm,et al. Erectile function and risk of Parkinson's disease. , 2007, American journal of epidemiology.
[64] Y. Kayama,et al. Control of sleep and wakefulness by brainstem monoaminergic and cholinergic neurons. , 2003, Acta neurochirurgica. Supplement.
[65] I. Alafuzoff,et al. Applicability of current staging/categorization of α-synuclein pathology and their clinical relevance , 2008, Acta Neuropathologica.
[66] T. Iwatsubo,et al. Lewy Body Pathology Involves Cutaneous Nerves , 2008, Journal of neuropathology and experimental neurology.
[67] H. Berendse,et al. Idiopathic hyposmia as a preclinical sign of Parkinson's disease , 2004, Annals of neurology.
[68] Hansjürgen Bratzke,et al. Stages in the development of Parkinson’s disease-related pathology , 2004, Cell and Tissue Research.
[69] Thomas Hummel,et al. Olfactory loss may be a first sign of idiopathic Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.
[70] I. Akiguchi,et al. Spontaneous and artificial lesions of magnocellular reticular formation of brainstem deteriorate avoidance learning in senescence-accelerated mouse SAM , 1998, Brain Research.
[71] E. Wolters,et al. Cognitive dysfunction and dementia in Parkinson’s disease , 2004, Journal of Neural Transmission.
[72] H. Fibiger. The Neurobiological Substrates of Depression in Parkinson’s Disease: A Hypothesis , 1984, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[73] S. Isenmann,et al. Cardiac denervation occurs independent of orthostatic hypotension and impaired heart rate variability in Parkinson's disease. , 2009, Parkinsonism & related disorders.
[74] M. Marmot,et al. Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology? , 1995, Journal of neurology, neurosurgery, and psychiatry.
[75] G. Halliday,et al. The progression of pathology in longitudinally followed patients with Parkinson’s disease , 2008, Acta Neuropathologica.
[76] C. Tanner,et al. Pain in Parkinson's disease , 1986, Movement disorders : official journal of the Movement Disorder Society.
[77] P. Pahapill,et al. The pedunculopontine nucleus and Parkinson's disease. , 2000, Brain : a journal of neurology.
[78] G. Logroscino,et al. Use of antidepressants and the risk of Parkinson’s disease: a prospective study , 2009, Journal of Neurology, Neurosurgery, and Psychiatry.
[79] R. Mayeux,et al. Altered serotonin metabolism in depressed patients with Parkinson's disease , 1984, Neurology.
[80] J. Sutcliffe,et al. The hypocretins: Excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding , 2000, Journal of neuroscience research.
[81] C. van Weel,et al. Symptoms and duration of the prodromal phase in parkinson's disease , 1997, Movement disorders : official journal of the Movement Disorder Society.
[82] Alain Dagher,et al. Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years , 2008, Nature Medicine.
[83] L. Findley,et al. Abnormality of taste and smell in Parkinson's disease. , 2009, Parkinsonism & related disorders.
[84] A. Lees,et al. Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.
[85] J. Blundell,et al. Dose–response effects of orexin-A on food intake and the behavioural satiety sequence in rats , 2000, Regulatory Peptides.
[86] H. Przuntek,et al. Early Diagnosis and Preventive Therapy in Parkinson’s Disease , 1989, Key Topics in Brain Research.
[87] C. Brayne,et al. Prospective association between emotional health and clinical evidence of Parkinson’s disease , 2008, European journal of neurology.
[88] H. Braak,et al. A not entirely benign procedure: progression of Parkinson’s disease , 2008, Acta Neuropathologica.
[89] H. Braak,et al. Staging of Sporadic Parkinson Disease-Related α-Synuclein Pathology: Inter- and Intra-Rater Reliability , 2005, Journal of neuropathology and experimental neurology.
[90] R. Paffenbarger,et al. Body mass index and risk of Parkinson's disease: a prospective cohort study. , 2007, American journal of epidemiology.
[91] E. Tolosa,et al. The premotor phase of Parkinson's disease. , 2007, Parkinsonism & related disorders.
[92] K. Gwinn‐Hardy,et al. Pain in Parkinson's disease , 2001, Postgraduate medicine.
[93] K. Sethi,et al. Levodopa unresponsive symptoms in Parkinson disease , 2008, Movement disorders : official journal of the Movement Disorder Society.